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Expression of gastrin, a gut hormone and growth fac-
tor, has tissue-specific transcriptional regulation and
can be induced in some tumors. Previous studies have
shown that a CACC cis-regulatory element is important
for transcriptional activation in pancreatic insulinoma
cells. To identify CACC-binding proteins, a l phage
cDNA library derived from a rat insulinoma cell line,
RIN 38A, was screened by a Southwestern method. A
novel member of the Cys2-His2 zinc finger gene family
was cloned and designated RIN ZF, having a cDNA se-
quence of 3.8 kilobases. One full-length and a shorter
splice variant were sequenced and had predicted pro-
tein masses of 91.6 and 88.7 kDa. Expression of both
splice forms were ubiquitous in fetal and adult rat tis-
sues. Recombinant RIN ZF protein exhibited sequence-
specific binding to the gastrin CACC element in a gel
mobility shift assay. In transient transfections, both
splice variants appeared to have only weak activating
effects on gastrin-luciferase reporter gene transcrip-
tion. Furthermore, RIN ZF coexpression with Sp1 ap-
peared to block the strongly activating effects of Sp1
mediated through the CACC element. These findings
suggest that a novel set of zinc finger proteins may help
regulate gastrin gene expression by interfering with Sp1
transactivation.
Gastrin, a peptide hormone and growth factor of the gastro-
intestinal tract, is expressed in a developmental and tissue-
specific manner. In development, gastrin is highly expressed in
fetal pancreatic islet precursor cells and in the fetal colon (1, 2).
After birth, expression greatly diminishes in those sites and
shifts to expression in the stomach and proximal small intes-
tine. Gastrin expression occurs in adenocarcinoma of the colon
(3) and pancreas (4) and in some pancreatic endocrine tumors.
In these neoplastic tissues, gastrin functions as a tumor growth
factor. Therefore, elucidation of transcriptional control mecha-
nisms may provide insights into induction of oncofetal gene
expression in neoplasia.
Transgenic studies with rat-human gastrin gene hybrids
demonstrate appropriate tissue-specific and developmental ex-
pression as long as the promoter contains proximal 59-flanking
sequence joined to the first exon (5). Further studies have
shown that gastrin transcriptional regulation is in large part
mediated through trans-factor interactions along the proximal
59-flanking sequence (5, 6). Multiple cis-regulatory elements
have been identified in the gastrin promoter, including Sp1
sites (7, 8), homeodomain-like elements (8), a negative element
(9), E-box binding sites (10), an epidermal growth factor-regu-
lated protein binding site (11), and a CACC element (6).
Systematic scanning mutagenesis of the proximal gastrin
promoter suggests that the CACC element, located approxi-
mately 110 bp1 from the transcriptional start site, is necessary
for promoter activity in rat insulinoma (8) and human colon
cancer cell lines (12). Mutational analysis of the CACC element
showed a close correlation between DNA binding by protein
complexes and transcriptional activation of gastrin-luciferase
reporter genes in insulinoma cell lines. Efforts to purify DNA-
binding proteins by sequence-specific affinity chromatography
(13) were successful, but the yield was too low for peptide
sequencing (6). Therefore, a different approach was followed by
probing electrophoretic blots of insulinoma cell extracts with
multimerized CACC element DNA probes. These Southwestern
blots revealed several DNA-binding protein bands from 70–110
kDa in size (6). Sequence specificity of the DNA binding was
verified by probing with a multimerized analog of the CACC
element containing two base mutations. The same mutations
rendered a gastrin-luciferase reporter gene functionally inac-
tive, and hence, when used as a southwestern probe, clearly
differentiated specific from nonspecific binding. In the current
study, a Southwestern binding approach was employed to
screen a l phage, insulinoma cDNA expression library for
CACC-binding proteins.
EXPERIMENTAL PROCEDURES
cDNA Library Construction and Screening—RIN 38A cell total RNA
preparation and two rounds of poly(A) selection (oligo(dT)-cellulose spin
column; Amersham Pharmacia Biotech) were accomplished by estab-
lished methods (14). A l gt11 cDNA library was then commercially
prepared (Stratagene, La Jolla, CA). Subsequent screening of the li-
brary for CACC DNA binding employed the Southwestern blot method
of Singh and co-workers (15). The unamplified library (106 plaque-
forming units) was plated with Y1090 bacteria and induced with iso-
propyl-1-thio-b-galactoside-coated nitrocellulose filters for 6 h. Filters
were then treated and probed as described previously (6). Nick-trans-
lated, double-stranded DNA probes were prepared from concatamers of
CACC element containing sequences (CCCCACCCCAT)6 (wild type
minimal CACC element), (CCCCACCCCATTCCTCTCGCCTGGA)4
(wild type), and (CCACACCACATTCCTCTCGCCTGGA)4 (mutant gas-
trin promoter elements). After four rounds of plaque isolation, those
phage positive for wild type binding and negative for the mutant probe
were amplified and prepared (lambda kit, Qiagen, Valencia, CA). Phage
cDNA inserts were subcloned into pGem 7 vectors (Promega, Madison,
WI) and sequenced by dideoxy sequencing methods (Sequenase; Amer-
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sham Pharmacia Biotech). Subsequent rounds of library screening for
cDNA fragments overlapping with clone 25A were accomplished by
nucleic acid hybridization with nick-translated fragments of EcoRI/SalI
25A and EcoRI/Bsu1 25B digests. Clone 25F had approximately 75%
GC content, which necessitated sequencing by the Maxim-Gilbert
chemical method (14). All cDNA fragments subcloned in pGEM 7 were
sequenced along both sense and antisense strands to confirm the se-
quence information. Sequence formatting, assembly, and analysis were
aided by MacVector and AssemblyLIGN programs (Oxford Molecular
Group, PLC) and GenBank 228 (National Center for Biotechnology
Information).
RT-PCR Analysis of RIN ZF Expression—Total RNA was prepared
from fresh BALB/c rat tissues by established methods (14). Fetal rat
tissues were obtained on approximately days 5–7 of gestation. cDNA
transcripts were synthesized from a 20-ml reaction of 1 mg of total RNA
in 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 5 mM MgCl2, 20 units of RNase
inhibitor (RNasin, Promega), 25 units of M-murine leukemia virus
reverse transcriptase (New England Biolabs, Beverly, MA), and 20
pmol of a RIN ZF antisense primer, 59-TGATCCCGTGATGAAGTCAG-
GCCATCTCTA (double underline, Fig. 2). After incubation at 42° for
1 h, the reaction was stopped by heating to 95 °C for 5 min. The reaction
was diluted to 100 ml and the buffer adjusted to 50 mM KCl, 10 mM
Tris-HCl (pH 8.3), 1.5 mM MgCl2, and 20 pmol of a RIN ZF forward
primer, 59-GCGGTACTCCAATGATACTG (underline, Fig. 2) was
added. The reaction was heated to 95 °C and cooled to 80 °C before 2.5
units of Taq polymerase (AmpliTaq, Perkin-Elmer) was added to start
the PCR reaction for a total of 35 cycles (94 °C/30 s, 60 °C/30 s, 72 °C/2
min).
Recombinant RIN ZF Protein Production—A 59-truncated version of
RIN ZFsv was developed by PCR amplification from clone 25C of a
962-bp fragment (bases 1181–2143) that was subsequently ligated into
the SalI site of clone 25A-pGem 7. The recombinant product was then
excised with BamHI digest and ligated into a pGex 2T bacterial expres-
sion vector (Amersham Pharmacia Biotech). Recombinant glutathione
S-transferase (GST), GST-truncated RIN ZFsv, and GST-Elk were ex-
pressed in JM109 Escherichia coli by a modified bacterial expression
method (17). Briefly, transformed bacteria were grown at 37 °C over-
night on LB ampicillin (50 mg/ml) plates. The bacterial colonies were
then suspended into LB broth (100 mg/ml ampicillin, 0.2 mM isopropyl-
1-thio-b-galactoside, 10 mM ZnSO4) and incubated at 30 °C for 3 h (200
rpm shaking) before harvest and protein extraction. Extracts were
prepared by sonication and purified by glutathione-Sepharose affinity
binding by well established methods (18). Gel mobility shift assays were
by previously described methods (6).
Transfection of SL 2 Cells and Recombinant Protein Expression—The
full-length coding region and 39-untranslated sequences of RIN ZF and
RIN ZFsv were excised and ligated in-frame with a start codon into an
actin promoter-driven expression vector, pPac (19). The coding region
and 39-untranslated region for clone 25A, designated truncated RIN ZF
(Fig. 5A), was ligated in-frame with a start site into a pPac expression
vector. Expression of all three versions was confirmed by in vitro tran-
scription and translation (data not shown). Gastrin-luciferase reporter
plasmids (6) included one with a proximal gastrin promoter and another
with a concatamer of the CACC element. The 200 Gas-Luc plasmid has
200 bp of 59-flanking sequence and noncoding exon 1 of human gastrin
ligated to the coding sequence for luciferase. The (CACC)6 pT81Luc
plasmid has a 6-mer of CCCCACCCCAT oligonucleotide from the CACC
element ligated to a heterologous thymidine kinase promoter and lucif-
erase reporter gene. Drosophila SL2 cells were passaged in complete
Schneider’s media (Life Technologies, Inc.) supplemented with 10%
fetal bovine serum 1 day before transfection. Plasmid preparations
were by anionic exchange resin (Qiagen) and subsequent Ca3(PO4)2-
mediated transfection into 6-well plates (35-mm wells) was by estab-
lished methods (18). Expression and reporter gene plasmids were co-
transfected in equivalent amounts (0.5 mg/well), and cells were
harvested for luciferase and Bradford protein assays (20) at 48 h post-
transfection. Transfected wells were in triplicate, and each experiment
was repeated four times for confirmation.
RESULTS
RIN ZF Cloning—A l gt11 phage expression library was
constructed from poly(A)-selected RNA obtained from RIN 38A
cells, a rat insulinoma cell line. Previously, several DNA-bind-
ing proteins demonstrating sequence-specific binding to the
CACC element in the gastrin promoter were detected in nu-
clear extracts from RIN 38A cells. Approximately 1 3 106
plaque-forming units of phage were screened by a Southwest-
ern binding assay using a nick-translated-labeled six-copy con-
catamer of the human gastrin CACC element. Twelve positive
clones were identified and subsequently screened with a mu-
tated CACC concatamer probe to verify sequence specificity.
Four true-positive CACC-binding phage isolates were then
plaque-purified. After subcloning and sequencing the cDNA
inserts, gene fragments homologous to rat Sp1 (accession num-
ber D12768) (20) and closely homologous to mouse Pur-1 (95%
identity, accession number L04649) (21) and human SPR-2
(94% identity, accession number X68560) (22) were identified.
All of the cDNA inserts identified in this assay for CACC
binding possessed zinc finger domains of the Cys2-His2 type,
including one, clone 25A, which otherwise had no close homol-
ogy with known genes. The latter clone was chosen for further
investigation.
Clone 25A was fully sequenced and found to be 2082 bases
long and had an open reading frame (ORF) from the 59 end
extending 1413 bases. Within the 25A ORF were two complete
and one partial Cys2-His2 zinc finger domains. The subsequent
screening, plaque purification, subcloning, and sequencing of
cDNA fragments homologous to 25A is shown in schematic
form in Fig. 1. cDNA fragments 25B, C, D, and E were identi-
fied by screening for homology to the 59-Sal fragment of 25A.
Clones 25B and E were identical in their overlapping regions,
as were 25C and D. However, the pairs differed from each other
presumably by splice variation in an 87-base pair region that
was not present in 25C and D. A 59-Bsu fragment from 25B was
then used to screen the library for the clone 25F. The overlap-
ping sequences of 25F with 25B–E were identical. As shown in
Fig. 2, assembly of the overlapping 25A–F-cloned fragments
yielded a cDNA sequence of 3850 bases.
Analysis of the assembled cDNA sequence revealed a single
long ORF from 674 to 3180 (Fig. 2). The ATG codon from base
674 is within a favorable context for initiation (23). This puta-
tive initiator codon has three upstream, in-frame terminator
codons. Of the other three upstream ATG sequences present,
all are out-of-frame and have a very weak context for initiation.
The full-length ORF encodes a putative protein of 836 amino
acids in length with a predicted molecular weight of 91 kDa. As
previously noted, several of the cDNA sequences differed in the
lack of an 87-base pair sequence shown in Fig. 2 in the boxed
sequence. This apparent splice variation is located between
bases 1457 and 1544, which is equivalent to a 29-codon differ-
ence. The exon donor and recipient half-sites conform with
known splice site consensus motifs (24). The predicted molec-
ular weight of the smaller splice variant is 89 kDa. The zinc
finger motifs are of the Cys2-His2 type and are located near the
COOH-terminal region. Two complete zinc finger domains and
one partial domain are present and have the typical seven-
codon HC connector sequences. However, these sequences are
not similar to the Krüppel consensus motifs (25). Gapped
BLAST (V2.0) (16) sequence analysis of the RIN ZF DNA and
FIG. 1. Schematic diagram of cDNA clones isolated from RIN
38A lgt11 phage library. Clones A, B, E, and F had identical se-
quences in overlapping segments, whereas clones C and D were iden-
tical except for the splice variation. Hatch marks denote 500 bases. Zinc
finger domain is noted in the boxed ZF, and the splice site is marked by
triangulating lines.
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its translated sequences did not find any matches or close
homologies with known genes.
RIN ZF mRNA Expression—To determine the expression of
the RIN ZF genes, poly(A)-selected RNA from Rin 38A, Rin B6,
and Rin 1056 cell lines were probed in Northern blot analysis.
Only three weak bands were detected at approximately 2.0, 5.0,
and 9.0 kb in size (data not shown). An RT-PCR approach was
then employed to determine the tissue and developmental ex-
pression pattern of the RIN ZF genes. Oligonucleotide primers
flanking the putative splice sites were used in the RT-PCR
assay shown in Fig. 3. Panels of adult and fetal rat RNA
samples were screened and yielded the predicted PCR products
of 791 and 704 bp in size. Both PCR products were isolated,
subcloned, and sequenced, confirming their identity with the
selected regions of the full-length and splice variant cDNA
library clones. The RIN ZF gene appears to be ubiquitously
expressed, having message present in all the fetal and adult rat
tissues tested. Although both forms of RIN ZF were detected,
the relative expression of each may be variable because this
RT-PCR assay was not quantitative. RNA from RIN cell lines
38A, B2, B6, 1056C, rat fibroblast Rat2, myoblast L8, and
pancreatic AR42J cell lines also yielded PCR products of 791
and 704 bp (data not shown).
Recombinant RIN ZF Gel Mobility Shift Assay—An expres-
sion vector for GST fusion-RIN ZF protein was developed by
ligating an in-frame sequence of a truncated form of the splice
variant into pGEX 2T vector. Recombinant GST-RinZF protein
was prepared and had an approximate molecular size of 66 kDa
(data not shown). Recombinant GST, GST-Elk, and GST-RIN
ZF were used in a gel mobility shift assay with a gastrin CACC
element probe. As shown in Fig. 4, only the GST-RIN ZF had
CACC DNA binding and probe shift. The GST-RIN ZF binding
was sequence-specific, because 50-fold excess of cold wild type
competitor oligonucleotide completely competed probe binding.
However, a 50-fold excess of an oligonucleotide with a 2-bp
mutation failed to compete. Therefore, recombinant RIN ZF
FIG. 2. RIN ZF cDNA sequence with open reading frame trans-
lation. Boxed bases identify the splice variation. Double-dotted under-
lined bases denote the zinc finger domains. Single and double-under-
lined bases denote forward and reverse PCR primer sites, respectively.
The translated sequence of RIN ZF ORF is noted in italics.
FIG. 3. Reverse transcriptase PCR amplification of RIN ZF
primed mRNA from rat tissues. Total RNA was isolated from fetal
and adult rat tissues and used in RT-PCR reaction as noted under
“Experimental Procedures.” RIN 38A cell total RNA is denoted as 38A,
with (1RT) or without (2RT) reverse transcriptase enzyme. RT-PCR
products and DNA size markers were resolved on 1.5% agarose gel. RIN
ZF primers encompassed the splice variation region as noted in Fig. 2.
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has the correct sequence specificity of DNA-binding proteins
that interact with the gastrin CACC cis-regulatory element. It
is noteworthy that the doublet banding pattern of the gel-
shifted probe obtained with GST-RIN ZF is similar to that
previously observed with Rin 38A nuclear extracts (6).
RIN ZF Activation of Gastrin-Luciferase Expression—It was
initially predicted that RIN ZF would be an activating tran-
scription factor because the CACC element was a positive cis-
regulatory element in the gastrin promoter. However, initial
results of expression of RIN ZF in mammalian cells showed
only weak activation, perhaps because of the presence of other
transcription factors. Therefore, RIN ZF expression vectors
were transfected into Drosophila SL2 cells, as they had no
Sp1-like activity (26). As shown in Fig. 5A, pPac vectors for the
expression of full-length, splice variant, and 59-truncated forms
of RIN ZF were utilized. These expression vectors were cotrans-
fected into SL2 cells with a proximal gastrin promoter lucifer-
ase reporter gene, and the results shown in Fig. 5B. The full-
length and splice variant versions had only modest activating
effects on 200 Gastrin-Luc reporter gene expression, resulting
in 2–3-fold increase over the empty vector, pPac. A 59-truncated
version of RIN ZF lacking 365 codons of the 59-coding region
but still possessing the zinc finger domains failed to activate
the reporter gene expression. Because the function of some zinc
finger transcription factors may be concentration-dependent
(28), RIN ZF expression plasmids were transfected over a con-
centration range of 0.05–2.0 mg/well. However, there was no
significant change in the overall pattern of weak transcrip-
tional activation of gastrin-luciferase expression (data not
shown).
To examine whether RIN ZFsv can act synergistically with
Sp1 or inhibit Sp1 transactivation, expression plasmids for
both were cotransfected into SL2 cells with a (CACC)6pT81Luc
reporter gene. As shown in Fig. 6, Sp1 strongly transactivated
CACC-Luc expression compared with the modest transactiva-
tion associated with RIN ZFsv. When the two expression vec-
tors were cotransfected in equivalent amounts, the CACC-Luc
transactivation was 80% lower than the Sp1 alone. Increasing
the amounts of RIN ZFsv further diminished but did not com-
pletely block the Sp1 effect. Similar results were obtained from
cotransfection of the full-length form of RIN ZF with Sp1 (data
not shown). These results suggest that RIN ZF does not act
synergistically with Sp1 but rather completes for binding to the
CACC element.
DISCUSSION
Several hundred transcription factors have been cloned and
identified by a variety of methods over the past decade (27).
Some, like Sp1, were identified after purification of the native
factor by DNA affinity chromatography (13). Although this
approach was initially applied to the gastrin CACC-binding
FIG. 4. Gel mobility shift assay with CACC oligonucleotide
probe and recombinant extracts of GST, GST-Elk, and GST-RIN
ZF proteins. Bacterial expression extracts were prepared, and recom-
binant GST fusion proteins were purified by affinity binding to gluta-
thione beads as described under “Experimental Procedures.” Equiva-
lent volumes (25 ml) of purified extracts were mixed with 32P-labeled
wild type CACC oligonucleotide probe (CCCCACCCCATTCCTCTCGC-
CTGGA). A 50-fold excess of unlabeled wild type (WT) CACC or mutant
(Mut) CACC (CCACACCACATTCCTCTCGCCTGGA) oligonucleotides
were added as competitors where indicated. After electrophoresis in 4%
nondenaturing polyacrylamide gel, the gel was dried and exposed to
film for 12 h.
FIG. 5. Transfection of SL-2 cells with RIN ZF expression vec-
tors and 200 Gastrin-Luc reporter genes. A, schematic diagram of
RIN ZF-coding sequences in pPac actin promoter expression vectors.
Each RIN ZF plasmid contained the zinc finger DNA binding domains
but had varying lengths of amino-terminal ends. B, SL-2 cells were
transiently transfected with pPac RIN ZF plasmids or empty pPac
plasmid and a gastrin-luciferase reporter plasmid containing 200 bp of
59-flanking sequence of the gastrin promoter. Luciferase and protein
assays were conducted at 48 h after transfection. Data are relative light
units/mg of protein in triplicate samples. aa, amino acids.
FIG. 6. Co-transfection of SL-2 cells with RIN ZF and Sp1 ex-
pression vectors and a (CACC)6 pT 81 Luc reporter gene. A pPac
Sp1 plasmid (0.25 mg/well) was cotransfected with varying amounts of
the splice variant RIN ZF, pPac plasmid (0–1 mg/well). Empty vector
pPac was cotransfected to maintain equivalent total plasmid amounts
in each transfection. Six copies of concatamerized CACC elements in a
heterologous pT81 Luc vector served as the reporter gene. Luciferase
reporter gene activity and protein assays were conducted 48 h after
transfection. Data are relative light units (RLU)/mg of protein in trip-
licate samples.
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protein (6), it proved to be impractical given the low abundance
of the CACC binding factors. An alternative approach of
screening of a cDNA expression library by DNA binding (28)
was pursued because several CACC-binding proteins ranging
in size from 70–110 kDa were evident on a Southwestern blot
of RIN 38A cell extracts (6). Potential disadvantages of this
approach are that many transcription factors do not retain
their DNA binding properties under the screening conditions,
and some require co-factors or dimerization to bind in a se-
quence-specific manner. In addition, DNA-binding proteins
possessing broad sequence specificity can generate false posi-
tive clones (29). With these caveats in mind, screening a RIN
38A cDNA library yielded several clones that showed strong
binding activity to a concatamer of the gastrin CACC element.
A secondary screen with mutant CACC concatamer probe ver-
ified sequence specificity by RIN ZF and several known zinc
finger transcription factors. To ensure that RIN ZF CACC
binding was not an artifact of a concatamerized probe, se-
quence specificity was confirmed by gel mobility shift assay
with a monomeric CACC element probe.
As previously noted, although several CACC binding pro-
teins were detected in RIN cell nuclear extracts, a 70-kDa
protein appeared most prominent. Interestingly, none of the
positive clones identified in the Southwestern screen appeared
to encode a 70-kDa protein. Although unlikely, it is possible
that RIN ZF and the 70-kDa protein are the same if RIN ZF has
an alternative translational initiation site from the one pre-
dicted by ORF analysis. A number of viral and cellular genes
have been identified that yield multiple protein products re-
sulting from alternative initiation of translation. It has been
observed that growth factor and transcription factor mRNAs
possessing long G 1 C-rich 59-untranslated regions exhibit
alternative translation initiation, often through internal ribo-
some entry sites (30–32). Similarly, RIN ZF has greater than
75% G 1 C content in the 59 kilobases of sequence, which likely
has significant secondary structure inhibitory of ribosomal
scanning. The issue of the relative size of native RIN ZF pro-
teins remains to be resolved by immunoblotting studies with
antisera prepared against recombinant RIN ZF.
Apart from the Cys2-His2 zinc finger domains, the RIN ZF
coding sequence bears little resemblance to other reported zinc
finger genes. Specifically, there were no Krüppel (25) or BTB
domains (33), which were first described in Drosophila but are
common in higher organisms. Other transcription factor do-
mains such as homeotic (34, 35), leucine zipper (36, 37), Ets
(38), and basic helix-loop-helix (39) also were not found in RIN
ZF. Subdividing the RIN ZF coding sequence and searching by
BLAST alignment failed to reveal any close homology with
known genes. However, searching an expressed sequence-
tagged data base revealed a close match with an expressed
sequence tag derived from microdissected human prostatic in-
traepithelial neoplasia 2 cells (accession number AA602975).
This 299-bp expressed sequence tag overlapped 221 bases of
the RIN ZF from 2044 to 2265, with an homology of 94%. In
separate studies, we used the RIN ZF PCR primers and DNA
prepared from a human gastric tumor cell line, AGS, to amplify
the splice site domains. After subcloning the PCR products,
sequencing revealed a 98% homology between rat and human
sequences (data not shown). These results suggest that RIN ZF
is a conserved gene and has a human homolog.
The mRNA expression pattern of RIN ZF is not limited to
those tissues that express gastrin. Both splice forms appear to
be ubiquitously expressed and not developmentally regulated.
However, these observations are limited by the RT-PCR
method to a qualitative assessment of message in whole tis-
sues. Immunohistochemistry with antisera specific to the full-
length and splice variant forms of RIN ZF would better define
the expression pattern and perhaps provide insights into func-
tionality. It is noteworthy that some zinc finger transcription
factors are developmentally regulated by expression of alter-
natively spliced variants (40). Several transcription factors
were found to have splice variations in the DNA binding do-
mains (41) as well as in activation or repression domains (42).
However, the RIN ZF splice site domain, which is 59 to the zinc
finger domains, consists of largely neutral amino acids and has
no recognizable motif. Therefore the functional differences be-
tween the splice variants remains to be determined.
Both full-length and splice variant RIN ZF appeared to have
weak trans-activating effects on the gastrin promoter, whereas
the truncated form had no effect (Fig. 5B). These results indi-
cate that within the RIN ZF amino-terminal region is an acti-
vation domain, despite the lack of recognizable activation mo-
tifs, such as homopolymeric glutamine and proline-rich
stretches (43). Instead, RIN ZF possesses several regions rich
in basic residues, often associated with repressor domains (44).
It may be that RIN ZF have intrinsically weak transactivation
domains or may require the presence of coactivating factors
(45) not present in the Drosophila cells. Some zinc finger pro-
teins contain both activation and repression domains (46) and
may be regulated by the context of the promoter binding site or
transcriptional cofactors. Further studies with chimeric RIN
ZF deletional constructs are in progress to determine func-
tional activity of RIN ZF domains.
It has been shown that some zinc finger proteins, such as
Krüppel,haveopposite regulatoryeffects thatareconcentration-
dependent (47). Sauer and Jäckle (47) found that monomers of
Krüppel activate, whereas dimers repress transcription even
though both forms bind to the same element. In contrast, RIN
ZF expression vector did not vary in its activating effects on
gastrin-luciferase transcription throughout a wide concentra-
tion range. Alternatively, RIN ZF may have a down-regulatory
effect on gastrin transcription by interfering with Sp1 binding
or function. BKLF, or basic Krüppel-like factor, is one example
of a zinc finger protein that competes with Sp1 binding at a
CACCC element of the b-globin gene in erythroid cells (48).
Similarly, ZBP-89 competes with Sp1 in binding to a GC-rich
proximal element in the gastrin gene (49). As Merchant and
her colleagues have shown (49), ZBP-89 inhibits Sp1 binding
and blocks epidermal growth factor induction of gastrin tran-
scription. Other mechanisms of altering Sp1 activity include
functional interactions with other transcription factors (50),
changing the Sp1 phosphorylation state (51) or targeting Sp1
for proteolysis (52). The most likely mechanism is that RIN ZF
competes with Sp1 binding at the CACC element, but further
studies are needed to determine binding affinities and
footprints.
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